Keywords: pharma, now, israeli, biotech, sales, israel, biotechnology
Pharma "now 71.5% of Israeli biotech sales"
Article | 25 May 2001
Sales in Israel's biotechnology sector advanced 33% to $800 million lastyear, with pharmaceuticals representing 71.5% of the sector's total turnover, up from 66.9% in 1999, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
